Regulations.gov document
Enclosure 1 - "Abbott Laboratories Comment to FDA/CFSAN/ONLDS" - [FDA/CFSAN to the…
Supporting & Related Material · FDA-2009-Q-0301 · posted Jun 9, 2011
Key facts
| Document ID | FDA-2009-Q-0301-0029 |
|---|---|
| Title | Enclosure 1 - "Abbott Laboratories Comment to FDA/CFSAN/ONLDS" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028 |
| Document type | Supporting & Related Material |
| Subtype | LET-Letter (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2009-Q-0301 |
| Posted | Jun 9, 2011 |
| Effective date | May 23, 2011 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: